Inhibin is a novel paracrine factor for tumor angiogenesis and metastasis P Singh, LM Jenkins, B Horst, V Alers, S Pradhan, P Kaur, T Srivastava, ... Cancer research 78 (11), 2978-2989, 2018 | 39 | 2018 |
FASN inhibition as a potential treatment for endocrine-resistant breast cancer A Gruslova, B McClellan, HU Balinda, S Viswanadhapalli, V Alers, ... Breast Cancer Research and Treatment, 1-12, 2021 | 23 | 2021 |